Interleukin-6, a mental cytokine.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Brain Research Reviews

• Publication date

  2011-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainresrev.2011.01.002PMID 21238488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Increased Pro-Inflammatory Response by Dendritic Cells from Patients with Alzheimer's Disease

  2010cited by this paper
• IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes

  2010cited by this paper
• Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat.

  2010cited by this paper
• Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice.

  2010cited by this paper
• Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation.

  2010cited by this paper
• Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition

  2010cited by this paper
• Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation.

  2010influential reference
• Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models

  2010cited by this paper
• Interleukin-6 upregulates the expression of PMP22 in cultured rat Schwann cells via a JAK2-dependent pathway.

  2010cited by this paper
• Cytokines Genes Polymorphisms and Risk of Multiple Sclerosis

  2010cited by this paper
• CSF Biomarkers for Alzheimer's Disease Diagnosis

  2010cited by this paper
• IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase

  2009cited by this paper
• IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease

  2009cited by this paper
• Interleukin‐6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration

  2009cited by this paper
• Molecular dissection of reactive astrogliosis and glial scar formation.

  2009cited by this paper
• Site-Specific Production of IL-6 in the Central Nervous System Retargets and Enhances the Inflammatory Response in Experimental Autoimmune Encephalomyelitis1

  2009cited by this paper
• Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation1

  2009cited by this paper
• Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK.

  2009cited by this paper
• Interleukin-6 Induces Prostaglandin E2 Synthesis in Mouse Astrocytes

  2009cited by this paper
• Epistasis in sporadic Alzheimer's disease.

  2009influential reference
• Context‐dependent IL‐6 potentiation of interferon‐ gamma‐induced IL‐12 secretion and CD40 expression in murine microglia

  2009cited by this paper
• Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.

  2009cited by this paper
• Interleukin-6 and neural stem cells: more than gliogenesis.

  2009cited by this paper
• Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation.

  2009cited by this paper
• Cytokines decrease expression of interleukin‐6 signal transducer and leptin receptor in central nervous system glia

  2009cited by this paper
• Neuronal IκB Kinase β Protects Mice from Autoimmune Encephalomyelitis by Mediating Neuroprotective and Immunosuppressive Effects in the Central Nervous System1

  2009cited by this paper
• Expression profiling and Ingenuity biological function analyses of interleukin-6- versus nerve growth factor-stimulated PC12 cells

  2009cited by this paper
• P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL‐6 release in hippocampal cultures

  2009cited by this paper
• Gene–gene interaction between CARD8 and interleukin-6 reduces Alzheimer’s disease risk

  2009influential reference
• Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic Aspects

  2009cited by this paper
• Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice.

  2009cited by this paper
• Inflammatory markers in AD and MCI patients with different biomarker profiles.

  2009cited by this paper
• IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.

  2008cited by this paper
• IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

  2008influential reference
• Ciliary neurotrophic factor and interleukin‐6 differentially activate microglia

  2008cited by this paper
• Interleukin-6 and Nerve Growth Factor Upregulation Correlates with Improved Outcome in Children with Severe Traumatic Brain Injury

  2008cited by this paper
• Effect of astrocyte‐targeted production of IL‐6 on traumatic brain injury and its impact on the cortical transcriptome

  2008cited by this paper
• Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.

  2008cited by this paper
• Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia

  2008cited by this paper
• Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

  2008cited by this paper
• Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells.

  2008cited by this paper
• Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease--preliminary report.

  2008cited by this paper
• Interleukin-6 Upregulates Neuronal Adenosine A1 Receptors: Implications for Neuromodulation and Neuroprotection

  2008cited by this paper
• IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis

  2008cited by this paper
• Minimal role for STAT1 in interleukin‐6 signaling and actions in the murine brain

  2008cited by this paper
• STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury

  2008cited by this paper
• Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.

  2008cited by this paper
• Inflammation‐related genes and the risk of Parkinson’s disease: a multilocus approach

  2008cited by this paper
• Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease1

  2008cited by this paper
• Interleukin‐6 induces proliferation in adult spinal cord‐derived neural progenitors via the JAK2/STAT3 pathway with EGF‐induced MAPK phosphorylation

  2008cited by this paper
• Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

  2008cited by this paper
• Interleukin-6 Upregulates Neuronal Adenosine A1 Receptors: Implications for Neuromodulation and Neuroprotection

  2008cited by this paper
• Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

  2008cited by this paper
• Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

  2008influential reference
• Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation

  2007cited by this paper
• Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils.

  2007cited by this paper
• The origin and application of experimental autoimmune encephalomyelitis

  2007cited by this paper
• Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6

  2007cited by this paper
• Microglia derived from aging mice exhibit an altered inflammatory profile

  2007cited by this paper
• Microglia‐derived interleukin‐6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells

  2007cited by this paper
• TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology

  2007cited by this paper
• Faculty Opinions recommendation of TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

  2007cited by this paper
• Hypoxic Preconditioning Induces Neuroprotective Stanniocalcin-1 in Brain via IL-6 Signaling

  2007cited by this paper
• The IL-6/sIL-6R complex as a novel target for therapeutic approaches

  2007cited by this paper
• Analysis of the Cerebral Transcriptome in Mice Subjected to Traumatic Brain Injury: Importance of IL-6

  2007cited by this paper
• The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro.

  2007cited by this paper
• Induction of neuronal and myelin-related gene expression by IL-6-receptor/IL-6: a study on embryonic dorsal root ganglia cells and isolated Schwann cells.

  2007cited by this paper
• Interleukin-6 protects cerebellar granule neurons from NMDA-induced neurotoxicity.

  2007influential reference
• Cytokines are a therapeutic target for the prevention of inflammation-induced cancers.

  2007cited by this paper
• Interleukin‐6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures

  2007cited by this paper
• Janus faces of microglia in multiple sclerosis.

  2007cited by this paper
• IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors.

  2006cited by this paper
• Interleukin‐6 attenuates the development of experimental diabetes‐related neuropathy

  2006cited by this paper
• Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.

  2006cited by this paper
• Increased expression of the β4 and α5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-α in the central nervous system

  2006cited by this paper
• Reconstitution of human immunodeficiency virus-induced neurodegeneration using isolated populations of human neurons, astrocytes, and microglia and neuroprotection mediated by insulin-like growth factors

  2006cited by this paper
• Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury

  2006cited by this paper
• Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice.

  2006cited by this paper
• Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system.

  2006cited by this paper
• IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.

  2006cited by this paper
• Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain.

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats.

  2006influential reference
• The Cytokine Interleukin-6 Is Sufficient But Not Necessary to Mimic the Peripheral Conditioning Lesion Effect on Axonal Growth

  2006influential reference
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Interaction between dopamine β-hydroxylase and interleukin genes increases Alzheimer’s disease risk

  2006cited by this paper
• Is there an immunologic basis for schizophrenia?

  2005cited by this paper
• IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

  2005cited by this paper
• Cytokines as mediators of depression: what can we learn from animal studies?

  2005cited by this paper
• Administration of monoclonal antibodies neutralizing the inflammatory mediators tumor necrosis factor alpha and interleukin -6 does not attenuate acute behavioral deficits following experimental traumatic brain injury in the rat

  2005cited by this paper
• A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis

  2005influential reference
• Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity.

  2005influential reference
• Interaction between interleukin–6 and intercellular adhesion molecule–1 genes and Alzheimer’s disease risk

  2005influential reference
• Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease

  2005cited by this paper
• Role of IL-6 in spinal cord injury in a mouse model

  2005cited by this paper
• INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION

  2005cited by this paper
• Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons

  2005cited by this paper

• The Immuno-Glial Connectome in Alzheimer’s Disease: Integrating Central and Peripheral Inflammatory Networks

  2026cites this paper
• Cytokine–Microglia Interactions in Neuroinflammation: Mechanisms, Disease Dynamics, and Therapeutic Strategies

  2025cites this paper
• IL-6 Induces Mitochondrial ROS Production and Blunts NO Bioavailability in Human Aortic Endothelial Cells.

  2025cites this paper
• A Novel Missense Variant in SORBS2 Is Causative With Familial Alzheimer's Disease

  2025cites this paper
• Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice

  2025cites this paper
• Effect of Interleukin-6 on Long-Term Potentiation Induction and Development in Rat Hippocampal Slices

  2025cites this paper
• Brain interleukins and Alzheimer’s disease

  2025cites this paper
• Neuronal hyperexcitability in dystrophin-deficient mdx hippocampal neurons: the importance of interleukin-6 and GABAergic regulation

  2025cites this paper
• Beyond CTLA-4 and PD-1: Novel Insights into MAO-A as a Next- Generation Immune Checkpoint Modulator for Cancer Immunotherapy.

  2025cites this paper
• Andrographolide Reduces Cytokine Release and Cyclooxygenase-2 Expression by Inhibiting the JNK and NF-κB Pathways in Glioblastoma Cells Exposed to Cadmium

  2025cites this paper
• Cytokine Blockade Attenuates Inflammation and Improves Depressive Psychopathology After COVID-19: A Naturalistic Observational Study

  2025cites this paper
• Subfield-specific hippocampal microstructural alterations in schizophrenia: A high-resolution DTI study.

  2025cites this paper
• The associations of peripheral interleukin alterations and hippocampal subfield volume deficits in schizophrenia.

  2024cites this paper
• Microglia Colonization Associated with Angiogenesis and Neural Cell Development.

  2024cites this paper
• Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities

  2024cites this paper
• Fluoxetine attenuates chlorpyrifos-induced neuronal injury through the PPARγ, SIRT1, NF-κB, and JAK1/STAT3 signals.

  2024cites this paper
• The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions

  2024cites this paper
• The relationship between plasma interleukin-6 and cognition based on curve correlation in drug-naïve patients with major depressive disorder.

  2024cites this paper
• Chemical structure and immunomodulatory activity of a polysaccharide from Saposhnikoviae Radix.

  2024cites this paper
• Decoding Paradoxical Links of Cytokine Markers in Cognition: Cross talk between Physiology, Inflammaging, and Alzheimer's Disease- Related Cognitive Decline.

  2024cites this paper
• Inflammation and Connexin 43 profiles in the prefrontal cortex are relevant to stress susceptibility and resilience in mice.

  2024cites this paper
• Preconditioning of Mesenchymal Stem Cells Enhances the Neuroprotective Effects of Their Conditioned Medium in an Alzheimer’s Disease In Vitro Model

  2024cites this paper
• Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

  2024cites this paper
• Distinctive Patterns of 5-Methylcytosine and 5-Hydroxymethylcytosine in Schizophrenia

  2024cites this paper
• Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination

  2024cites this paper
• Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs.

  2024cites this paper
• Advances in mesenchymal stem cell-centered stem cell therapy in the treatment of hypoxic-ischemic injury.

  2024cites this paper
• Repercussions of microglial efferocytosis on neurodegeneration in Alzheimer’s Disease (AD): a double-edged sword and perplexing factor warranting scrutiny in AD research

  2024cites this paper
• Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project

  2024cites this paper
• Human olfactory neural progenitor cells reveal differences in IL-6, IL-8, thrombospondin-1, and MCP-1 in major depression disorder and borderline personality disorder

  2024cites this paper
• Perioperative Levels of IL8 and IL18, but not IL6, are Associated with Nucleus Basalis Magnocellularis Atrophy Three Months after Surgery

  2024cites this paper
• Natural Products as Potential Modulators of Pro-Inflammatory Cytokines Signalling in Alzheimer's Disease

  2024cites this paper
• Inflammation in Posttraumatic Stress Disorder: Dysregulation or Recalibration?

  2023cites this paper
• Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article

  2023cites this paper
• Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials

  2023cites this paper
• Drugs to Treat Neuroinflammation in Neurodegenerative Disorders.

  2023cites this paper
• Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants

  2023cites this paper
• ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation

  2023cites this paper
• Behavioral and inflammatory changes in rats induced by a three-hit stress model: Implications for psychiatric disorders.

  2023cites this paper
• Febrile Seizure Causes Deficit in Social Novelty, Gliosis, and Proinflammatory Cytokine Response in the Hippocampal CA2 Region in Rats

  2023cites this paper
• Impact of Elevated Brain IL-6 in Transgenic Mice on the Behavioral and Neurochemical Consequences of Chronic Alcohol Exposure

  2023cites this paper
• Oxidative Stress Markers in Human Brain and Placenta May Reveal the Timing of Hypoxic-Ischemic Injury: Evidence from an Immunohistochemical Study

  2023cites this paper
• The effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes.

  2023cites this paper
• Anti-Inflammatory Activity of Synaptamide in the Peripheral Nervous System in a Model of Sciatic Nerve Injury

  2023cites this paper
• Neuroimaging of complications arising after CD19 chimeric antigen receptor T‐cell therapy: A review

  2023cites this paper
• Physical activity in a swimming pool attenuates memory impairment by reducing glutamate and inflammatory cytokines and increasing BDNF in the brain of mice with type 2 diabetes.

  2023cites this paper
• Bacteriophages as Potential Clinical Immune Modulators

  2023influential citation
• Implicative role of Cytokines in Neuroinflammation mediated AD and associated signaling pathways: Current Progress in molecular signaling and therapeutics.

  2023cites this paper
• Effects of Xenon on Neuroinflammatory Markers: a Prospective Pilot Study

  2023cites this paper
• Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure

  2022cites this paper
• Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases

  2022influential citation
• Additive Impact of Interleukin 6 and Neuron Specific Enolase for Prognosis in Patients With Out-of-Hospital Cardiac Arrest – Experience From the HAnnover COoling REgistry

  2022influential citation
• Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity

  2022cites this paper
• Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia?

  2022cites this paper
• Strawberry notch homolog 2 regulates the response to interleukin-6 in the central nervous system

  2022cites this paper
• Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease

  2022cites this paper
• Apnea induced by respiratory syncytial virus infection: an inappropriate immune response requiring long-term follow-up for adult-onset progressive neurodegenerative diseases?

  2022cites this paper
• Chimeric Structures in Mental Illnesses—“Magic” Molecules Specified for Complex Disorders

  2022cites this paper
• Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial

  2022cites this paper
• Association of childhood maltreatment history with salivary interleukin-6 diurnal patterns and C-reactive protein in healthy adults.

  2022cites this paper
• Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases

  2022cites this paper
• High plasma IL-6 levels following haploidentical allogeneic hematopoietic stem cell transplantation post-transplant cyclophosphamide as predictor of early death with worse outcome.

  2022cites this paper
• Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome

  2022cites this paper
• Effects of Dexamethasone and Pentoxifylline on Mania-like and Depression-like Behaviors in Rats

  2022cites this paper
• Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder

  2022cites this paper
• Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6/JAK2/STAT3 Pathway in Parkinson’s Disease Model

  2022influential citation
• The protective effects of curcumin on depression: Genes, transcription factors, and microRNAs involved.

  2022cites this paper
• An integrated cytokine and kynurenine network as the basis of neuroimmune communication

  2022cites this paper
• An overview of multiplexed analyses of CAR T-cell therapies: insights and potential

  2021cites this paper
• Inflammatory cytokines TNFα, IL-1β, and IL-6 are induced in endotoxin- stimulated microglia through different signaling cascades

  2021cites this paper
• Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease

  2021influential citation
• Characterisation of the Mouse Cerebellar Proteome in the GFAP-IL6 Model of Chronic Neuroinflammation

  2021cites this paper
• Aging, demented patients and polymorphisms in cytokine genes

  2021cites this paper
• Potential Prognostic Markers and Molecules of Acute Pancreatitis- A Review

  2021cites this paper
• Meningoencephalitis in relapsing polychondritis

  2021cites this paper
• Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population.

  2021cites this paper
• Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder.

  2021influential citation
• Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

  2021cites this paper
• Neurodegenerative phosphoprotein signaling landscape in models of SCA3

  2021cites this paper
• Bio-indicators in cadmium toxicity: Role of HSP27 and HSP70

  2021cites this paper
• On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?

  2021cites this paper
• The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration

  2021cites this paper
• Exposure to cadmium induces neuroinflammation and impairs ciliogenesis in hESC-derived 3D cerebral organoids.

  2021cites this paper
• Chronic exposure to IL-6 induces a desensitized phenotype of the microglia

  2021cites this paper
• Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis

  2020cites this paper
• Compilação sobre possíveis biomarcadores para doença de Alzheimer

  2020cites this paper
• Transcriptional alterations in opioid use disorder reveal an interplay between neuroinflammation and synaptic remodeling

  2020cites this paper
• Polarized Cytokine Release Triggered by P2X7 Receptor from Retinal Pigmented Epithelial Cells Dependent on Calcium Influx

  2020cites this paper
• The effect of insomnia on development of Alzheimer’s disease

  2020cites this paper
• Bacteriophage K1F targets Escherichia coli K1 in cerebral endothelial cells and influences the barrier function

  2020cites this paper
• IL-6 Trans-Signaling in the Brain Influences the Metabolic Phenotype of the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Mesenchymal Stromal Cells Suppress Hippocampal Neuron Autophagy Stress Induced by Hypoxic-Ischemic Brain Damage: The Possible Role of Endogenous IL-6 Secretion

  2020cites this paper
• Wpływ interleukiny 6 na sen i chorobę Alzheimera

  2020cites this paper
• Psychiatric face of COVID-19

  2020cites this paper
• Alterations in inflammatory markers and clinical outcome after spontaneous intracerebral hemorrhage - Preliminary results.

  2020cites this paper
• Possible Long-Term Effects of Childhood Maltreatment on Cognitive Function in Adult Women With Posttraumatic Stress Disorder

  2020cites this paper
• Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer's disease neuroimaging initiative database.

  2020cites this paper
• Exposure to lead in the pre- and neonatal periods may result in brain inflammation

  2020cites this paper
• The Cytokine Interleukin 6 (IL-6) as a Neural and Endocrine Regulator

  2020cites this paper